| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.32B | +14.8% |
| Cost of Revenue | $270.8M | +31.7% |
| Gross Profit | $1.05B | +11.2% |
| R&D Expense | $362.4M | +15.8% |
| SG&A Expense | $233.0M | +7.1% |
| Operating Income | -$124.3M | +8.9% |
| Pre-tax Income | -$94.0M | +9.8% |
| Income Tax | $6.8M | +283.2% |
| Net Income | -$100.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $480.7M | +9.8% |
| Short-term Investments | $287.8M | -14.8% |
| Accounts Receivable | $287.8M | +16.8% |
| Current Assets | $1.17B | +6.1% |
| Total Assets | $2.24B | +6.6% |
| Current Liabilities | $884.6M | +21.5% |
| Total Liabilities | $976.8M | +20.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $300.3M | +53.1% |
| Capital Expenditures | $18.1M | -5.4% |
| Investing Cash Flow | -$70.5M | +53.0% |
| Financing Cash Flow | -$178.9M | -593.7% |
| Free Cash Flow | $282.2M | +59.4% |
| +4.9% |
| EPS (Basic) | -$0.67 | +6.9% |
| EPS (Diluted) | -$0.67 | +6.9% |
| Stockholders' Equity |
| $1.26B |
| -2.0% |